Alamar Biosciences Revenue and Competitors

Location

#3348

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Alamar Biosciences's estimated annual revenue is currently $17.2M per year.(i)
  • Alamar Biosciences's estimated revenue per employee is $155,000
  • Alamar Biosciences's total funding is $250M.

Employee Data

  • Alamar Biosciences has 111 Employees.(i)
  • Alamar Biosciences grew their employee count by 25% last year.

Alamar Biosciences's People

NameTitleEmail/Phone
1
Founder, COOReveal Email/Phone
2
Founder, Chairman & CEOReveal Email/Phone
3
Founder, VP TechnologyReveal Email/Phone
4
Co-founder, VP TechnologyReveal Email/Phone
5
VP, Biopharma Business DevelopmentReveal Email/Phone
6
SVP MarketingReveal Email/Phone
7
Chief Technology OfficerReveal Email/Phone
8
Senior Director Application SupportReveal Email/Phone
9
Senior Director ManufacturingReveal Email/Phone
10
Sr. Director, Commercial MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Alamar Biosciences?

Alamar Biosciences’ mission is to transform the field of proteomics for early detection of cancer and other diseases. Following in the footsteps of genomics, proteomes will usher in a new era of precision health. The human plasma proteome, the complete set of proteins in human blood, has long been recognized as a gold mine of health and disease biomarkers. However, due to the low abundance and wide dynamic range of these proteins in the plasma, most of the plasma proteome has remained inaccessible with current technologies. We are creating the world’s most sensitive proteomics platform to unmask the deepest secrets of our proteome. Our fully automated, high throughput platform will empower new biomarker discoveries for early detection and prevention of common diseases.

keywords:N/A

$250M

Total Funding

111

Number of Employees

$17.2M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.9M111-7%$22M
#2
$23.5M11296%N/A
#3
$27.2M112-1%N/A
#4
$17.4M1127%N/A
#5
$25.1M1140%$1.5M